World Journal of Surgery

, Volume 28, Issue 11, pp 1110–1114 | Cite as

Preoperative Neck Ultrasonographic Mapping for Persistent/Recurrent Papillary Thyroid Cancer

  • Hussam M. BinYousef
  • Ali S. AlzahraniEmail author
  • Saif S. Al-Sobhi
  • Hamed S. Al Suhaibani
  • Mohammed A. Chaudhari
  • Hussain M. Raef


Surgical resection of persistent/recurrent (P/R) papillary thyroid cancer (PTC), when localized to the neck, is generally recommended; however, its impact on the course of the disease is not clear. We introduced a new technique in the form of preoperative neck ultrasonographic mapping (US-M) to improve the outcome of the surgical resection of P/R PTC. A total of 19 patients had undergone regional (central, lateral, or both) neck dissection before introducing the current technique (group 1, or G1), and 26 patients (group 2, or G2) had limited lymph node resection guided by US-M with findings accurately plotted on a standard diagram. All of the operations were performed by a single surgeon. The surgical outcomes of the two groups were compared. The resected lesions were positive for PTC in 17 patients (89.5%) in G1 and in 25 patients (96.2%) in G2. In G2, the intraoperative findings exactly matched the US-M in 23 patients (88.5%). Postoperatively, neck US became negative in 50% in G1 and in 83.3% in G2 (p = 0.02). Thyroglobulin (Tg) became undetectable in 37.5% in G1 and 52.3% in G2 (p = 0.37). Whole-body iodine scans (WBS) became negative in one of six patients (16.7%) in G1, and in three of four patients (75%) in G2, (p = 0.06). After a mean follow-up of 23.8 ± 7.1 months in G1 and 9.8 ± 4.7 months in G2, 6 patients (31.6%) in G1 and 15 patients (62.5%) in G2 were in remission (p = 0.04), whereas the disease persisted in 13 cases (68.4%) in G1 and 9 (37.5%) in G2 (p = 0.04). In conclusion, US-M improved the surgical outcome, as evidenced by the postoperative US, Tg, and WBS findings and the higher remission rate for the G2 patients than for the G1 patients.


Neck Dissection Papillary Thyroid Cancer Whole Body Scan 131I Therapy Modify Neck Dissection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Wartofsky, L, Sherman, SI, Gopal, J,  et al. 1998The use of radioactive iodine in patients with papillary and follicular thyroid cancerJ. Clin. Endocrinol. Metab.8341954203CrossRefPubMedGoogle Scholar
  2. 2.
    McDougall, IR 1997131I treatment of 131I negative whole body scan, and positive thyroglobulin in differentiated thyroid carcinoma: what is being treated?Thyroid7669672PubMedGoogle Scholar
  3. 3.
    Mazzaferri, EL 1995Treating high thyroglobulin with radioiodine: a magic bullet or a shot in the dark?J. Clin. Endocrinol. Metab.8014851487CrossRefPubMedGoogle Scholar
  4. 4.
    Singer, PA, Cooper, DS, Daniels, GH,  et al. 1996Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid AssociationArch. Intern. Med.15621652172CrossRefPubMedGoogle Scholar
  5. 5.
    Mazzaferri, EL, Kloos, RT 2001Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancerJ. Clin. Endocrinol. Metab.8614471463CrossRefPubMedGoogle Scholar
  6. 6.
    Goretzki, PE, Simon, D, Frilling, A,  et al. 1993Surgical reintervention for differentiated thyroid cancerBr. J. Surg.8010091012PubMedGoogle Scholar
  7. 7.
    Clark, OH, Hoelting, T 1994Management of patients with differentiated thyroid cancer who have positive serum thyroglobulin levels and negative radioiodine scansThyroid4501505PubMedGoogle Scholar
  8. 8.
    Coburn, M, Teates, D, Wanebo, HJ 1994Recurrent thyroid cancer: role of surgery versus radioactive iodine (I131)Ann. Surg.219587595PubMedGoogle Scholar
  9. 9.
    Alzahrani, AS, Raef, H, Sultan, A,  et al. 2002Impact of cervical lymph node dissection on serum TG and the course of disease in TG-positive, radioactive iodine whole body scan-negative recurrent/persistent papillary thyroid cancerJ. Endocrinol. Invest.25526531PubMedGoogle Scholar
  10. 10.
    Mazzaferri, EL, Jhiang, SM 1994Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerAm. J. Med.97418428CrossRefPubMedGoogle Scholar
  11. 11.
    Hay, ID, Thompson, GB, Grant, CS,  et al. 2002Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patientsWorld J. Surg.26879885CrossRefPubMedGoogle Scholar
  12. 12.
    Schlumberger, MJ 1998Papillary and follicular thyroid carcinomaN. Engl. J. Med.338297306Google Scholar
  13. 13.
    Grebe, SK, Hay, ID 1996Thyroid cancer nodal metastases: biologic significance and therapeutic considerationsSurg. Oncol. Clin. N. Am.54363PubMedGoogle Scholar
  14. 14.
    DeGroot, LJ 1994Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancerAm. J. Med.97499500CrossRefPubMedGoogle Scholar
  15. 15.
    Boland, GW, Lee, MJ, Mueller, PR,  et al. 1993Efficacy of sonographically guided biopsy of thyroid masses and cervical lymph nodesAJR Am. J. Roentgenol.16110531056PubMedGoogle Scholar
  16. 16.
    Sutton, RT, Reading, CC, Charboneau, JW,  et al. 1988US-guided biopsy of neck masses in postoperative management of patients with thyroid cancerRadiology168769772PubMedGoogle Scholar
  17. 17.
    Simeone, JF, Daniels, GH, Hall, DA,  et al. 1987Sonography in the follow-up of 100 patients with thyroid carcinomaAJR Am. J. Roentgenol.1484549PubMedGoogle Scholar
  18. 18.
    Pacini, F, Lippi, F, Formica, N,  et al. 1987Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levelsJ. Nucl. Med.2818881891PubMedGoogle Scholar
  19. 19.
    Schlumberger, M, Arcangioli, O, Piekarski, JD,  et al. 1988Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-raysJ. Nucl. Med.2917901794PubMedGoogle Scholar
  20. 20.
    Pineda, JD, Lee, T, Ain, K,  et al. 1995Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scanJ. Clin. Endocrinol. Metab.8014881492CrossRefPubMedGoogle Scholar
  21. 21.
    Pacini, F, Agate, L, Elisei, R,  et al. 2001Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patientsJ. Clin. Endocrinol. Metab.8640924097CrossRefPubMedGoogle Scholar
  22. 22.
    Fatourechi, V, Hay, ID, Javedan, H,  et al. 2002Lack of impact of radioiodine therapy in tg-positive, diagnostic whole-body scan-negative patients with follicular cell-derived thyroid cancerJ. Clin. Endocrinol. Metab.8715211526CrossRefPubMedGoogle Scholar
  23. 23.
    McDougall, IR 2001Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful?J. Endocrinol. Invest.24194198PubMedGoogle Scholar
  24. 24.
    Travagli, JP, Cailleux, AF, Ricard, M,  et al. 1998Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinomaJ. Clin. Endocrinol. Metab.8326752680CrossRefPubMedGoogle Scholar
  25. 25.
    Salvatori, M, Rufini, V, Reale, F,  et al. 2003Radio-guided surgery for lymph node recurrences of differentiated thyroid cancerWorld J. Surg.27770775CrossRefPubMedGoogle Scholar
  26. 26.
    Desai, D, Jeffrey, RB, McDougall, IR,  et al. 2001Intraoperative ultrasonography for localization of recurrent thyroid cancerSurgery129498500CrossRefPubMedGoogle Scholar
  27. 27.
    Karwowski, JK, Jeffrey, RB, McDougall, IR,  et al. 2002Intraoperative ultrasonography improves identification of recurrent thyroid cancerSurgery132924929CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2004

Authors and Affiliations

  • Hussam M. BinYousef
    • 1
  • Ali S. Alzahrani
    • 2
    Email author
  • Saif S. Al-Sobhi
    • 1
  • Hamed S. Al Suhaibani
    • 3
  • Mohammed A. Chaudhari
    • 4
  • Hussain M. Raef
    • 2
  1. 1.Department of SurgeryKing Faisal Specialist Hospital & Research CentreRiyadhSaudi Arabia
  2. 2.Department of MedicineKing Faisal Specialist Hospital & Research CentreRiyadhSaudi Arabia
  3. 3.Department of RadiologyKing Faisal Specialist Hospital & Research CentreRiyadhSaudi Arabia
  4. 4.Epidemiology, Biostatistics, and Scientific ComputingKing Faisal Specialist Hospital & Research CentreRiyadhSaudi Arabia

Personalised recommendations